TickerFacts.

Medline Inc. (MDLN): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$3.22B
Year ended 2025-12-31
$2.84B
Trailing 12 months to 2026-06-27
2023-12-31: $2.20B2024-12-31: $3.12B2025-12-31: $3.22B$3.22B
2023-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$3.22B+3.2%2026-02-25, From 2025-01-01
2024-12-31$3.12B+41.9%2026-02-25, From 2024-01-01
2023-12-31$2.20Bn/a2026-02-25, From 2023-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Medline Inc. (MDLN)2025-12-31$3.22B+3.2%
Stryker Corp (SYK)2025-12-31$6.46B+26.3%
3M Co (MMM)2025-12-31$5.94B-4.0%
Becton Dickinson & Co (BDX)2025-09-30$5.04B+7.6%
Boston Scientific Corp (BSX)2025-12-31$4.98B+28.6%
Baxter International Inc (BAX)2025-12-31$673.00M-33.4%
Solventum Corp (SOLV)2025-12-31$2.67B+67.8%
ResMed Inc (RMD)2026-06-30$2.09B+10.8%
Dexcom Inc (DXCM)2025-12-31$1.16B+42.3%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗